Opioids Market - Global Outlook and Forecast 2023-2027

Report ID: 923619 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Opioids Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Opioids Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Opioids Overall Market Size
    2.1 Global Opioids Market Size: 2021 VS 2027
    2.2 Global Opioids Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Opioids Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Opioids Players in Global Market
    3.2 Top Global Opioids Companies Ranked by Revenue
    3.3 Global Opioids Revenue by Companies
    3.4 Global Opioids Sales by Companies
    3.5 Global Opioids Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Opioids Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Opioids Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Opioids Players in Global Market
        3.8.1 List of Global Tier 1 Opioids Companies
        3.8.2 List of Global Tier 2 and Tier 3 Opioids Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Opioids Market Size Markets, 2021 & 2027
        4.1.2 Oxycodone
        4.1.3 Hydromorphone
        4.1.4 Codeine
        4.1.5 Fentanyl
        4.1.6 Other
    4.2 By Type - Global Opioids Revenue & Forecasts
        4.2.1 By Type - Global Opioids Revenue, 2016-2021
        4.2.2 By Type - Global Opioids Revenue, 2022-2027
        4.2.3 By Type - Global Opioids Revenue Market Share, 2016-2027
    4.3 By Type - Global Opioids Sales & Forecasts
        4.3.1 By Type - Global Opioids Sales, 2016-2021
        4.3.2 By Type - Global Opioids Sales, 2022-2027
        4.3.3 By Type - Global Opioids Sales Market Share, 2016-2027
    4.4 By Type - Global Opioids Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Opioids Market Size, 2021 & 2027
        5.1.2 Pain Relief
        5.1.3 Anesthesia
        5.1.4 Cough Suppression
        5.1.5 Diarrhea Suppression
        5.1.6 Deaddiction
        5.1.7 Others
    5.2 By Application - Global Opioids Revenue & Forecasts
        5.2.1 By Application - Global Opioids Revenue, 2016-2021
        5.2.2 By Application - Global Opioids Revenue, 2022-2027
        5.2.3 By Application - Global Opioids Revenue Market Share, 2016-2027
    5.3 By Application - Global Opioids Sales & Forecasts
        5.3.1 By Application - Global Opioids Sales, 2016-2021
        5.3.2 By Application - Global Opioids Sales, 2022-2027
        5.3.3 By Application - Global Opioids Sales Market Share, 2016-2027
    5.4 By Application - Global Opioids Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Opioids Market Size, 2021 & 2027
    6.2 By Region - Global Opioids Revenue & Forecasts
        6.2.1 By Region - Global Opioids Revenue, 2016-2021
        6.2.2 By Region - Global Opioids Revenue, 2022-2027
        6.2.3 By Region - Global Opioids Revenue Market Share, 2016-2027
    6.3 By Region - Global Opioids Sales & Forecasts
        6.3.1 By Region - Global Opioids Sales, 2016-2021
        6.3.2 By Region - Global Opioids Sales, 2022-2027
        6.3.3 By Region - Global Opioids Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Opioids Revenue, 2016-2027
        6.4.2 By Country - North America Opioids Sales, 2016-2027
        6.4.3 US Opioids Market Size, 2016-2027
        6.4.4 Canada Opioids Market Size, 2016-2027
        6.4.5 Mexico Opioids Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Opioids Revenue, 2016-2027
        6.5.2 By Country - Europe Opioids Sales, 2016-2027
        6.5.3 Germany Opioids Market Size, 2016-2027
        6.5.4 France Opioids Market Size, 2016-2027
        6.5.5 U.K. Opioids Market Size, 2016-2027
        6.5.6 Italy Opioids Market Size, 2016-2027
        6.5.7 Russia Opioids Market Size, 2016-2027
        6.5.8 Nordic Countries Opioids Market Size, 2016-2027
        6.5.9 Benelux Opioids Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Opioids Revenue, 2016-2027
        6.6.2 By Region - Asia Opioids Sales, 2016-2027
        6.6.3 China Opioids Market Size, 2016-2027
        6.6.4 Japan Opioids Market Size, 2016-2027
        6.6.5 South Korea Opioids Market Size, 2016-2027
        6.6.6 Southeast Asia Opioids Market Size, 2016-2027
        6.6.7 India Opioids Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Opioids Revenue, 2016-2027
        6.7.2 By Country - South America Opioids Sales, 2016-2027
        6.7.3 Brazil Opioids Market Size, 2016-2027
        6.7.4 Argentina Opioids Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Opioids Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Opioids Sales, 2016-2027
        6.8.3 Turkey Opioids Market Size, 2016-2027
        6.8.4 Israel Opioids Market Size, 2016-2027
        6.8.5 Saudi Arabia Opioids Market Size, 2016-2027
        6.8.6 UAE Opioids Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Teva
        7.1.1 Teva Corporate Summary
        7.1.2 Teva Business Overview
        7.1.3 Teva Opioids Major Product Offerings
        7.1.4 Teva Opioids Sales and Revenue in Global (2016-2021)
        7.1.5 Teva Key News
    7.2 Purdue Pharma
        7.2.1 Purdue Pharma Corporate Summary
        7.2.2 Purdue Pharma Business Overview
        7.2.3 Purdue Pharma Opioids Major Product Offerings
        7.2.4 Purdue Pharma Opioids Sales and Revenue in Global (2016-2021)
        7.2.5 Purdue Pharma Key News
    7.3 Mallinckrodt
        7.3.1 Mallinckrodt Corporate Summary
        7.3.2 Mallinckrodt Business Overview
        7.3.3 Mallinckrodt Opioids Major Product Offerings
        7.3.4 Mallinckrodt Opioids Sales and Revenue in Global (2016-2021)
        7.3.5 Mallinckrodt Key News
    7.4 Amneal Pharma
        7.4.1 Amneal Pharma Corporate Summary
        7.4.2 Amneal Pharma Business Overview
        7.4.3 Amneal Pharma Opioids Major Product Offerings
        7.4.4 Amneal Pharma Opioids Sales and Revenue in Global (2016-2021)
        7.4.5 Amneal Pharma Key News
    7.5 Collegium
        7.5.1 Collegium Corporate Summary
        7.5.2 Collegium Business Overview
        7.5.3 Collegium Opioids Major Product Offerings
        7.5.4 Collegium Opioids Sales and Revenue in Global (2016-2021)
        7.5.5 Collegium Key News
    7.6 J&J
        7.6.1 J&J Corporate Summary
        7.6.2 J&J Business Overview
        7.6.3 J&J Opioids Major Product Offerings
        7.6.4 J&J Opioids Sales and Revenue in Global (2016-2021)
        7.6.5 J&J Key News
    7.7 Endo
        7.7.1 Endo Corporate Summary
        7.7.2 Endo Business Overview
        7.7.3 Endo Opioids Major Product Offerings
        7.4.4 Endo Opioids Sales and Revenue in Global (2016-2021)
        7.7.5 Endo Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Opioids Major Product Offerings
        7.8.4 Pfizer Opioids Sales and Revenue in Global (2016-2021)
        7.8.5 Pfizer Key News
    7.9 INSYS
        7.9.1 INSYS Corporate Summary
        7.9.2 INSYS Business Overview
        7.9.3 INSYS Opioids Major Product Offerings
        7.9.4 INSYS Opioids Sales and Revenue in Global (2016-2021)
        7.9.5 INSYS Key News
    7.10 Mylan
        7.10.1 Mylan Corporate Summary
        7.10.2 Mylan Business Overview
        7.10.3 Mylan Opioids Major Product Offerings
        7.10.4 Mylan Opioids Sales and Revenue in Global (2016-2021)
        7.10.5 Mylan Key News
    7.11 Hikma
        7.11.1 Hikma Corporate Summary
        7.11.2 Hikma Opioids Business Overview
        7.11.3 Hikma Opioids Major Product Offerings
        7.11.4 Hikma Opioids Sales and Revenue in Global (2016-2021)
        7.11.5 Hikma Key News
    7.12 Egalet
        7.12.1 Egalet Corporate Summary
        7.12.2 Egalet Opioids Business Overview
        7.12.3 Egalet Opioids Major Product Offerings
        7.12.4 Egalet Opioids Sales and Revenue in Global (2016-2021)
        7.12.5 Egalet Key News
8 Global Opioids Production Capacity, Analysis
    8.1 Global Opioids Production Capacity, 2016-2027
    8.2 Opioids Production Capacity of Key Manufacturers in Global Market
    8.3 Global Opioids Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Opioids Supply Chain Analysis
    10.1 Opioids Industry Value Chain
    10.2 Opioids Upstream Market
    10.3 Opioids Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Opioids Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
106
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Opioids Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opioids Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opioids Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports